Virtually all cutaneous melanomas harbor driver mutations that activate the RAS/RAF/MEK/ERK MAPK pathway [1], which facilitates the proliferation and survival of the tumor cells [2,3,4,5]. The gene discussed is MAP2K7; the disease is neoplasm.